At the beginning of the year, the FDA announced that it would limit regulation of certain “general wellness products,” including some healthcare wearables. While lowering the barrier to market entry for these products poses low risk and could encourage greater engagement with health metrics, clinicians will still have to serve as the buffer between patients…
